AL
Almirall
ALM.MC·BMEBarcelona ESFounded 19432,000 employees
Mid CappharmaPublicDermatology
Platform: Ebglyss Lebrik
Market Cap
$2B
All Drugs
2
Clinical Trials
4
Failed / Terminated
0
FDA Approved
1
Stock Price & Catalysts (ALM.MC)
Loading ALM.MC stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Fixalucimab | ALM-5174 | Phase 2 | 2 | VEGF | Cervical Ca | ||
| ALM-7482 | ALM-7482 | Approved | 2 | C5 | EoESCLC |
SEC Filings & Financial Documents
SEC filings are not available for BME-listed companies.
Almirall trades on BME (ES). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (4)